GF-3001

N/A

Report date: 2025/01/26 15:27:23

Base Information

Drug NameGF-3001
Drug Alias NameGF-3001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-6 activators
TargetsNAD-dependent protein deacetylase sirtuin-6
Therapy Area/IndicationsWerner Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenflow Biosciences PLC
China Registration ClassN/A

Develop Information

Active CompaniesGenflow Biosciences PLC
Inactive CompaniesN/A
Active IndicationsWerner Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A